Feedback
 
 
Specialty Pharmacy Times

Viewpoints: The Last Word

Viewpoints: The Last Word RSS Feed
Specialty Pharmacy
Putting “High-Tech, High-Touch” Back into Specialty Pharmacy
Gerry Crocker, Chief Executive Officer, CSPN
The roots of specialty pharmacy began in community retail pharmacy. Given a choice, specialty patients will choose a local specialty pharmacy to access their medicines and manage their care.
The Importance of Freedom to Operate for Specialty Biopharmaceuticals
Dimitris Dogramatzis, RPh, PhD
The exploration of the freedom to operate in the specialty biopharmaceutical market, which requires specific steps and processes.
Vendor Integration: Focus on Customer and Cost Leads Manufacturers to Novel Approach
Kevin Cast, Vice President, Strategy & Contracting, Pharma & Biotech, Express Scripts
Specialty pharmaceuticals, and the supporting patient and physician ancillary services, have emerged as a focal point for the majority of manufacturers. The increasing number of specialty drugs available in the United States, coupled with the heightened research and development focus of major pharmaceutical manufacturers on biotech therapies, has resulted in an unprecedented shift in dynamics across the prescription drug industry.
Oncology: Are You on the Right Path Through the Brewing Storm?
Phil Hagerman, RPh
Diplomat Specialty Pharmacy's president and chief executive officer shares his thoughts about the turbulent oncology arena and how specialty pharmacists can survive the storm and prosper.
Optimism and Opportunity
David Golding, RPh
Pharmacy Times
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Pharmacy Times 2006-2012
Intellisphere, LLC. All Rights Reserved.
 




Become a Member